Cipla is introducing leuprolide acetate injection depot, 22.5 mg, which is the generic of AbbVie’s Lupron Depot. It is indicated for palliative treatment of advanced prostate cancer. Leuprolide ...
AbbVie announced that a new 6-month 45mg Lupron Depot (leuprolide acetate for extended-release injectable suspension) strength has received Health Canada approval for the treatment of advanced ...
LUPRON DEPOT (leuprolide acetate for extended-release injectable suspension) is a hormonal medication first approved by Health Canada in 1989 for advanced prostate cancer, and later for various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback